US Stock MarketDetailed Quotes

AVIR Atea Pharmaceuticals

Watchlist
  • 3.730
  • +0.160+4.48%
Trading Jul 22 14:58 ET
314.15MMarket Cap-1912P/E (TTM)

Atea Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-33.55%-39.87M
29.42%-85.4M
-1.34%-21.83M
17.19%-17.59M
15.98%-16.12M
49.41%-29.85M
-39.05%-120.98M
71.43%-21.55M
-193.98%-21.24M
-10.59%-19.19M
Net income from continuing operations
-78.11%-63.17M
-17.30%-135.96M
-13.75%-39.16M
-310.89%-33.14M
10.06%-28.18M
15.71%-35.47M
-195.64%-115.91M
-129.40%-34.43M
71.39%-8.07M
-2,136.06%-31.34M
Depreciation and amortization
0.00%104K
60.00%416K
0.00%104K
-1.89%104K
141.86%104K
1,385.71%104K
796.55%260K
1,385.71%104K
1,414.29%106K
437.50%43K
Change In working capital
458.37%14.1M
134.69%16.16M
127.56%9.41M
133.07%7.38M
1,443.46%3.3M
86.25%-3.94M
81.20%-46.59M
102.03%4.14M
-156.08%-22.32M
100.74%214K
-Change in prepaid assets
119.65%5.08M
129.82%1.86M
-135.37%-4.16M
161.19%4.57M
-131.74%-862K
740.36%2.31M
-1,194.20%-6.25M
62.74%-1.77M
-648.02%-7.48M
55.73%2.72M
-Change in payables and accrued expense
250.97%9.07M
136.26%14.36M
366.39%13.61M
127.66%2.85M
216.97%3.91M
79.20%-6.01M
-173.12%-39.61M
141.36%2.92M
-148.59%-10.29M
-111.26%-3.34M
-Change in other current assets
--0
106.56%98K
--0
--0
--295K
---197K
-827.95%-1.49M
-2,363.64%-1.49M
--0
--0
-Change in other current liabilities
-7.32%-44K
-121.05%-161K
-17.14%-41K
0.00%-40K
-104.64%-39K
---41K
--765K
---35K
---40K
--840K
Cash from discontinued investing activities
Operating cash flow
-33.55%-39.87M
29.42%-85.4M
-1.34%-21.83M
17.19%-17.59M
15.98%-16.12M
49.41%-29.85M
-39.05%-120.98M
71.43%-21.55M
-193.98%-21.24M
-10.59%-19.19M
Investing cash flow
Cash flow from continuing investing activities
132.03%56.8M
108.85%40.3M
-17.07%27.77M
87.98%-58.51M
2,578.18%46.57M
55,736.36%24.48M
-11,385,150.00%-455.41M
837,300.00%33.49M
-486.98M
-1.88M
Net PPE purchase and sale
----
--0
--0
--0
----
----
-48,475.00%-1.94M
--0
---20K
---1.88M
Net investment purchase and sale
132.03%56.8M
108.89%40.3M
-17.07%27.77M
87.98%-58.51M
--46.57M
--24.48M
---453.47M
--33.49M
---486.96M
--0
Cash from discontinued investing activities
Investing cash flow
132.03%56.8M
108.85%40.3M
-17.07%27.77M
87.98%-58.51M
2,578.18%46.57M
55,736.36%24.48M
-11,385,150.00%-455.41M
837,300.00%33.49M
---486.98M
---1.88M
Financing cash flow
Cash flow from continuing financing activities
-9.09%150K
-30.54%257K
0
-37.41%92K
0
-26.01%165K
-74.74%370K
0
-81.51%147K
0
Proceeds from stock option exercised by employees
-9.09%150K
-30.54%257K
--0
-37.41%92K
--0
-26.01%165K
--370K
--0
-81.51%147K
--0
Cash from discontinued financing activities
Financing cash flow
-9.09%150K
-30.54%257K
--0
-37.41%92K
--0
-26.01%165K
-74.74%370K
--0
-81.51%147K
--0
Net cash flow
Beginning cash position
-23.77%143.82M
-75.33%188.66M
-21.97%137.89M
-68.76%213.9M
-74.01%183.45M
-75.33%188.66M
-10.06%764.68M
-78.96%176.72M
-16.14%684.79M
-15.35%705.85M
Current changes in cash
428.28%17.09M
92.22%-44.84M
-50.29%5.94M
85.04%-76.01M
244.53%30.45M
91.15%-5.21M
-573.36%-576.02M
115.86%11.94M
-2,271.42%-508.07M
-21.83%-21.07M
End cash Position
-12.29%160.91M
-23.77%143.82M
-23.77%143.82M
-21.97%137.89M
-68.76%213.9M
-74.01%183.45M
-75.33%188.66M
-75.33%188.66M
-78.96%176.72M
-16.14%684.79M
Free cash flow
-33.55%-39.87M
30.53%-85.4M
-1.34%-21.83M
17.27%-17.59M
23.47%-16.12M
49.45%-29.85M
-41.28%-122.93M
71.44%-21.55M
-194.07%-21.26M
-21.43%-21.07M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -33.55%-39.87M29.42%-85.4M-1.34%-21.83M17.19%-17.59M15.98%-16.12M49.41%-29.85M-39.05%-120.98M71.43%-21.55M-193.98%-21.24M-10.59%-19.19M
Net income from continuing operations -78.11%-63.17M-17.30%-135.96M-13.75%-39.16M-310.89%-33.14M10.06%-28.18M15.71%-35.47M-195.64%-115.91M-129.40%-34.43M71.39%-8.07M-2,136.06%-31.34M
Depreciation and amortization 0.00%104K60.00%416K0.00%104K-1.89%104K141.86%104K1,385.71%104K796.55%260K1,385.71%104K1,414.29%106K437.50%43K
Change In working capital 458.37%14.1M134.69%16.16M127.56%9.41M133.07%7.38M1,443.46%3.3M86.25%-3.94M81.20%-46.59M102.03%4.14M-156.08%-22.32M100.74%214K
-Change in prepaid assets 119.65%5.08M129.82%1.86M-135.37%-4.16M161.19%4.57M-131.74%-862K740.36%2.31M-1,194.20%-6.25M62.74%-1.77M-648.02%-7.48M55.73%2.72M
-Change in payables and accrued expense 250.97%9.07M136.26%14.36M366.39%13.61M127.66%2.85M216.97%3.91M79.20%-6.01M-173.12%-39.61M141.36%2.92M-148.59%-10.29M-111.26%-3.34M
-Change in other current assets --0106.56%98K--0--0--295K---197K-827.95%-1.49M-2,363.64%-1.49M--0--0
-Change in other current liabilities -7.32%-44K-121.05%-161K-17.14%-41K0.00%-40K-104.64%-39K---41K--765K---35K---40K--840K
Cash from discontinued investing activities
Operating cash flow -33.55%-39.87M29.42%-85.4M-1.34%-21.83M17.19%-17.59M15.98%-16.12M49.41%-29.85M-39.05%-120.98M71.43%-21.55M-193.98%-21.24M-10.59%-19.19M
Investing cash flow
Cash flow from continuing investing activities 132.03%56.8M108.85%40.3M-17.07%27.77M87.98%-58.51M2,578.18%46.57M55,736.36%24.48M-11,385,150.00%-455.41M837,300.00%33.49M-486.98M-1.88M
Net PPE purchase and sale ------0--0--0---------48,475.00%-1.94M--0---20K---1.88M
Net investment purchase and sale 132.03%56.8M108.89%40.3M-17.07%27.77M87.98%-58.51M--46.57M--24.48M---453.47M--33.49M---486.96M--0
Cash from discontinued investing activities
Investing cash flow 132.03%56.8M108.85%40.3M-17.07%27.77M87.98%-58.51M2,578.18%46.57M55,736.36%24.48M-11,385,150.00%-455.41M837,300.00%33.49M---486.98M---1.88M
Financing cash flow
Cash flow from continuing financing activities -9.09%150K-30.54%257K0-37.41%92K0-26.01%165K-74.74%370K0-81.51%147K0
Proceeds from stock option exercised by employees -9.09%150K-30.54%257K--0-37.41%92K--0-26.01%165K--370K--0-81.51%147K--0
Cash from discontinued financing activities
Financing cash flow -9.09%150K-30.54%257K--0-37.41%92K--0-26.01%165K-74.74%370K--0-81.51%147K--0
Net cash flow
Beginning cash position -23.77%143.82M-75.33%188.66M-21.97%137.89M-68.76%213.9M-74.01%183.45M-75.33%188.66M-10.06%764.68M-78.96%176.72M-16.14%684.79M-15.35%705.85M
Current changes in cash 428.28%17.09M92.22%-44.84M-50.29%5.94M85.04%-76.01M244.53%30.45M91.15%-5.21M-573.36%-576.02M115.86%11.94M-2,271.42%-508.07M-21.83%-21.07M
End cash Position -12.29%160.91M-23.77%143.82M-23.77%143.82M-21.97%137.89M-68.76%213.9M-74.01%183.45M-75.33%188.66M-75.33%188.66M-78.96%176.72M-16.14%684.79M
Free cash flow -33.55%-39.87M30.53%-85.4M-1.34%-21.83M17.27%-17.59M23.47%-16.12M49.45%-29.85M-41.28%-122.93M71.44%-21.55M-194.07%-21.26M-21.43%-21.07M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg